Q32 Bio CEO granted 132,000 performance-based RSUs

Q32 Bio Inc. CEO Jodie Pope Morrison reported an acquisition of 132,000 shares of common stock tied to performance-based restricted stock units granted on July 6, 2026.

Rhea-AI Filing Summary

Q32 Bio Inc. CEO Jodie Pope Morrison reported an acquisition of 132,000 shares of common stock tied to performance-based restricted stock units granted on July 6, 2026. The PSUs met a financing performance condition and remain subject to quarterly vesting over three years, bringing her direct holdings to 353,104 shares.

Insider Trade Summary

Grant/Award: 132,000 shares

Grant/Award 1 txn

Insider Morrison Jodie Pope

Role CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	132,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 353,104 shares (Direct)

Footnotes (1)

1. F1. Represents shares of Issuer common stock underlying performance-based restricted stock units ("PSUs") granted on July 6, 2026, which vested on July 16, 2026 with respect to a performance-based condition, upon achievement of the closing of a financing of at least $100,000,000 in gross proceeds on or before December 31, 2026. Such PSUs are also subject to a time-based condition, which provides that the PSUs shall vest in equal quarterly installments over three years from July 1, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. Each PSU represents a contingent right to receive one share of Issuer common stock.

Key Figures

PSUs underlying common stock: 132,000 shares Shares held after award: 353,104 shares Financing performance threshold: $100,000,000 +3 more

6 metrics

PSUs underlying common stock 132,000 shares Performance-based restricted stock units reported as acquired on July 16, 2026

Shares held after award 353,104 shares Direct common stock holdings of Jodie Pope Morrison following the transaction

Financing performance threshold $100,000,000 Gross proceeds required to satisfy the PSUs’ performance condition on or before December 31, 2026

Time-based vesting period three years PSUs vest in equal quarterly installments over three years from July 1, 2026

PSU grant date July 6, 2026 Date the performance-based restricted stock units were granted

Performance vesting date July 16, 2026 Date the PSUs vested with respect to the performance-based condition

Key Terms

performance-based restricted stock units, time-based condition, gross proceeds, contingent right

4 terms

performance-based restricted stock units financial

"Represents shares of Issuer common stock underlying performance-based restricted stock units ("PSUs") granted"

Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.

time-based condition financial

"Such PSUs are also subject to a time-based condition, which provides that the PSUs"

gross proceeds financial

"upon achievement of the closing of a financing of at least $100,000,000 in gross proceeds on or before"

The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

contingent right financial

"Each PSU represents a contingent right to receive one share of Issuer common stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity award did Q32 Bio (QTTB) CEO Jodie Pope Morrison report?

Jodie Pope Morrison reported acquiring 132,000 shares of common stock tied to performance-based restricted stock units (PSUs). These shares reflect PSUs that satisfied a financing performance condition and are also subject to a three-year, time-based vesting schedule.

How many Q32 Bio (QTTB) shares does the CEO hold after this transaction?

After the reported award, Jodie Pope Morrison directly holds 353,104 shares of Q32 Bio common stock. This figure includes the 132,000 shares underlying PSUs associated with the performance and time-based vesting conditions.

What performance condition is attached to the Q32 Bio (QTTB) CEO’s PSUs?

The PSUs are tied to a financing condition requiring at least $100,000,000 in gross proceeds from a closing on or before December 31, 2026. Achievement of this condition governs the performance-based vesting of the units.

What is the vesting schedule for the Q32 Bio (QTTB) CEO’s PSUs?

The PSUs are subject to a time-based condition and vest in equal quarterly installments over three years from July 1, 2026. Vesting is contingent on the CEO’s continued service through each applicable vesting date.

When were the Q32 Bio (QTTB) CEO’s PSUs granted and when did the performance condition vest?

The PSUs were granted on July 6, 2026 and vested with respect to their performance-based condition on July 16, 2026, upon achievement of the specified financing threshold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/20/2026 - 09:27 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Morrison Jodie Pope

(Last) (First) (Middle)

Q32 BIO INC.

830 WINTER STREET

(Street)

WALTHAM MASSACHUSETTS 02451

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Q32 Bio Inc. [ QTTB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/16/2026		A(1)		132,000	A	$0	353,104	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Issuer common stock underlying performance-based restricted stock units ("PSUs") granted on July 6, 2026, which vested on July 16, 2026 with respect to a performance-based condition, upon achievement of the closing of a financing of at least $100,000,000 in gross proceeds on or before December 31, 2026. Such PSUs are also subject to a time-based condition, which provides that the PSUs shall vest in equal quarterly installments over three years from July 1, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. Each PSU represents a contingent right to receive one share of Issuer common stock.

	/s/ Eric Bell, Attorney-in-Fact	07/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)